Megestrol acetate: Phase II study of a single daily administration in advanced breast cancer

1990 ◽  
Vol 17 (1) ◽  
pp. 51-54 ◽  
Author(s):  
Paolo Pronzato ◽  
Fulvio Brema ◽  
Domenico Amoroso ◽  
Gianfilippo Bertelli ◽  
Pier Franco Conte ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Megestrol Acetate ◽  
Daily Administration

Bromocriptin (B) and lanreotide (L) in advanced breast cancer: A phase II study

1993 ◽  
Vol 29 ◽  
pp. S84 ◽  
Author(s):  
J. Bonneterre ◽  
J.M. Plon ◽  
A. Adenis ◽  
J.P. Peyrat ◽  
S. Henane ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast

Centchroman—a non-steroidal anti-cancer agent for advanced breast cancer: Phase-II study

1989 ◽  
Vol 43 (5) ◽  
pp. 781-783 ◽  
Author(s):  
N. C. Misra ◽  
P. K. Nigam ◽  
Ruby Gupta ◽  
A. K. Agarwal ◽  
V. P. Kamboj
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Anti Cancer ◽  
Cancer Agent

A phase II study of losoxantrone (dup 941) in advanced breast cancer

1993 ◽  
Vol 29 ◽  
pp. S78
Author(s):  
W. Ten Bokkel Muinink ◽  
M. Moore ◽  
I. Smith ◽  
T. Vandenberg ◽  
M. Barbu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast

Vinorelbine as second line treatment in anthracycline pre-treated advanced breast cancer patients: A phase II study

1993 ◽  
Vol 29 ◽  
pp. S82 ◽  
Author(s):  
L. Dogliotti ◽  
G. Gorzegno ◽  
M.G. Bau ◽  
A. Farris ◽  
C. Bumma ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Line Treatment ◽  
Second Line ◽  
Breast Cancer Patients

A phase II study of 4-deoxydoxorubicin in advanced breast cancer

1987 ◽  
Vol 23 (7) ◽  
pp. 1079-1080 ◽  
Author(s):  
Elaine M. Rankin ◽  
Robert K. Knight ◽  
Robert D. Rubens
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast

Cisplatin — epirubicin — paclitaxel (PET) weekly administration with G-CSF support in advanced breast cancer (ABC). A phase II study

1999 ◽  
Vol 35 ◽  
pp. S318 ◽  
Author(s):  
G. Frasci ◽  
P. Comella ◽  
G. D'Aiuto ◽  
A. Apicella ◽  
R. Thomas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Weekly Administration

scholarly journals Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer

2018 ◽  
Vol 24 (18) ◽  
pp. 4380-4387 ◽  
Author(s):  
Maura N. Dickler ◽  
Cristina Saura ◽  
Donald A. Richards ◽  
Ian E. Krop ◽  
Andrés Cervantes ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Hormone Receptor Positive
Sign in / Sign up

Export Citation Format

Share Document